Picture loading failed.

Anti-CD3E;CD33 therapeutic antibody (Pre-made Vixtimotamab biosimilar,Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody)) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).



Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-624-1mg 1mg 3090
GMP-Bios-ab-624-10mg 10mg 21890
GMP-Bios-ab-624-100mg 100mg 148000
GMP-Bios-ab-624-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-CD3E;CD33 therapeutic antibody (Pre-made Vixtimotamab biosimilar,Bispecific Homodimer (VK-VH-VL'-VH', Tandem diabody))
INN Name Vixtimotamab
TargetCD3E;CD33
FormatBispecific Homodimer (VK-VH-VL'-VH', Tandem diabody)
DerivationBispecific antibody
Species ReactivityHuman
CH1 Isotypena;na
VD LCKappa;Lambda
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusActive
100% SI StructureNone;None
99% SI StructureNone;None
95-98% SI StructureNone;None
Year Proposed2020
Year Recommendedna
CompaniesAmphivena Therapeutics
Conditions Approvedna
Conditions ActiveAcute myeloid leukemia;Myelodysplastic syndromes
Conditions Discontinuedna
Development Techna